Found: 57
Select item for more details and to access through your institution.
Sorafenib, a dual Raf kinase/vascular endothelial growth factor receptor inhibitor has significant anti-myeloma activity and synergizes with common anti-myeloma drugs.
- Published in:
- Oncogene, 2010, v. 29, n. 8, p. 1190, doi. 10.1038/onc.2009.403
- By:
- Publication type:
- Article
Diagnosis of B-cell non-Hodgkin's lymphoma of the central nervous system by immunocytochemical analysis of cerebrospinal fluid lymphocytes.
- Published in:
- 1986
- By:
- Publication type:
- journal article
Epigenetic mechanisms of protein tyrosine phosphatase 6 suppression in diffuse large B-cell lymphoma: implications for epigenetic therapy.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 1, p. 147, doi. 10.1038/leu.2013.251
- By:
- Publication type:
- Article
High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myeloma.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 3, p. 680, doi. 10.1038/leu.2012.237
- By:
- Publication type:
- Article
A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 1, p. 220, doi. 10.1038/leu.2012.236
- By:
- Publication type:
- Article
Regulation of STAT3 by histone deacetylase-3 in diffuse large B-cell lymphoma: implications for therapy.
- Published in:
- Leukemia (08876924), 2012, v. 26, n. 6, p. 1356, doi. 10.1038/leu.2011.340
- By:
- Publication type:
- Article
Denileukin diftitox in combination with rituximab for previously untreated follicular B-cell non-Hodgkin's lymphoma.
- Published in:
- Leukemia (08876924), 2012, v. 26, n. 5, p. 1046, doi. 10.1038/leu.2011.297
- By:
- Publication type:
- Article
Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I study.
- Published in:
- Leukemia (08876924), 2011, v. 25, n. 12, p. 1877, doi. 10.1038/leu.2011.165
- By:
- Publication type:
- Article
The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma.
- Published in:
- Leukemia (08876924), 2011, v. 25, n. 9, p. 1502, doi. 10.1038/leu.2011.112
- By:
- Publication type:
- Article
Efficacy of thalidomide- or lenalidomide-based therapy in proliferative multiple myeloma.
- Published in:
- 2011
- By:
- Publication type:
- Letter
A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma.
- Published in:
- 2011
- By:
- Publication type:
- journal article
The de-ubiquitinase UCH-L1 is an oncogene that drives the development of lymphoma in vivo by deregulating PHLPP1 and Akt signaling.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Lymphopenia assessed during routine follow-up after immunochemotherapy (R-CHOP) is a risk factor for predicting relapse in patients with diffuse large B-cell lymphoma.
- Published in:
- Leukemia (08876924), 2010, v. 24, n. 7, p. 1343, doi. 10.1038/leu.2010.108
- By:
- Publication type:
- Article
Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains.
- Published in:
- Kidney International, 2008, v. 73, n. 11, p. 1282, doi. 10.1038/ki.2008.108
- By:
- Publication type:
- Article
Reply to ‘Claimed association of absolute lymphocyte count with therapeutic efficacy of radio-immunotherapy in patients with indolent lymphoma cannot be verified in an independence data set’ by Mark J Bishton et al.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Reply to ‘Rituximab in CD20 positive multiple myeloma’ by P Moreau et al.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Absolute lymphocyte count predicts therapeutic efficacy and survival at the time of radioimmunotherapy in patients with relapsed follicular lymphomas.
- Published in:
- 2007
- By:
- Publication type:
- letter
A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy.
- Published in:
- Leukemia (08876924), 2007, v. 21, n. 3, p. 529, doi. 10.1038/sj.leu.2404516
- By:
- Publication type:
- Article
CD45 expression by bone marrow plasma cells in multiple myeloma: clinical and biological correlations.
- Published in:
- Leukemia (08876924), 2005, v. 19, n. 8, p. 1466, doi. 10.1038/sj.leu.2403823
- By:
- Publication type:
- Article
A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.
- Published in:
- 2005
- By:
- Publication type:
- journal article
A phase I study of<sup>153</sup>Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.
- Published in:
- Leukemia (08876924), 2005, v. 19, n. 1, p. 118, doi. 10.1038/sj.leu.2403575
- By:
- Publication type:
- Article
Thalidomide as initial therapy for early-stage myeloma.
- Published in:
- Leukemia (08876924), 2003, v. 17, n. 4, p. 775, doi. 10.1038/sj.leu.2402866
- By:
- Publication type:
- Article
Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma.
- Published in:
- Leukemia (08876924), 2003, v. 17, n. 2, p. 427, doi. 10.1038/sj.leu.2402797
- By:
- Publication type:
- Article
A phase II study of sequential combination chemotherapy with cyclophosphamide, prednisone, and 2-chlorodeoxyadenosine in previously untreated patients with chronic lymphocytic leukemia.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Thalidomide for previously untreated indolent or smoldering multiple myeloma.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Anti-CD20 monoclonal antibody-dependent phagocytosis of chronic lymphocytic leukaemia cells by autologous macrophages.
- Published in:
- Clinical & Experimental Immunology, 2016, v. 183, n. 1, p. 90, doi. 10.1111/cei.12697
- By:
- Publication type:
- Article
Single agent dexamethasone for pre-stem cell transplant induction therapy for multiple myeloma.
- Published in:
- Bone Marrow Transplantation, 2004, v. 34, n. 6, p. 485, doi. 10.1038/sj.bmt.1704633
- By:
- Publication type:
- Article
Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy.
- Published in:
- Bone Marrow Transplantation, 2004, v. 34, n. 3, p. 235, doi. 10.1038/sj.bmt.1704555
- By:
- Publication type:
- Article
Effect of thalidomide on stem cell collection and engraftment in patients with multiple myeloma.
- Published in:
- Bone Marrow Transplantation, 2003, v. 32, n. 6, p. 587, doi. 10.1038/sj.bmt.1704173
- By:
- Publication type:
- Article
Effect of complete response on outcome following autologous stem cell transplantation for myeloma.
- Published in:
- Bone Marrow Transplantation, 2000, v. 26, n. 9, p. 979, doi. 10.1038/sj.bmt.1702640
- By:
- Publication type:
- Article
Delayed stem cell transplantation for the management of relapsed or refractory multiple myeloma.
- Published in:
- Bone Marrow Transplantation, 2000, v. 26, n. 1, p. 45, doi. 10.1038/sj.bmt.1702445
- By:
- Publication type:
- Article
Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.
- Published in:
- Bone Marrow Transplantation, 1999, v. 24, n. 5, p. 497, doi. 10.1038/sj.bmt.1701943
- By:
- Publication type:
- Article
Beta<sub>2</sub>-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myeloma.
- Published in:
- Bone Marrow Transplantation, 1999, v. 23, n. 12, p. 1261, doi. 10.1038/sj.bmt.1701787
- By:
- Publication type:
- Article
Autologous stem cell transplantation for relapsed and primary refractory myeloma.
- Published in:
- Bone Marrow Transplantation, 1999, v. 23, n. 12, p. 1267, doi. 10.1038/sj.bmt.1701805
- By:
- Publication type:
- Article
Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma.
- Published in:
- Bone Marrow Transplantation, 1999, v. 23, n. 3, p. 221, doi. 10.1038/sj.bmt.1701559
- By:
- Publication type:
- Article
Expression of the hematopoietic stem cell antigen CD34 on blood and bone marrow monoclonal plasma cells from patients with multiple myeloma.
- Published in:
- Bone Marrow Transplantation, 1997, v. 19, n. 6, p. 553, doi. 10.1038/sj.bmt.1700697
- By:
- Publication type:
- Article
Monoclonal plasma cells in the blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse-free survival after transplantation.
- Published in:
- Bone Marrow Transplantation, 1997, v. 19, n. 4, p. 337, doi. 10.1038/sj.bmt.1700670
- By:
- Publication type:
- Article
Thalidomide as an anti-cancer agent.
- Published in:
- Journal of Cellular & Molecular Medicine, 2002, v. 6, n. 2, p. 160, doi. 10.1111/j.1582-4934.2002.tb00184.x
- By:
- Publication type:
- Article
Depth of metabolic response at interim PET and survival outcomes among patients with primary refractory or early relapsing diffuse large B‐cell lymphoma (DLBCL).
- Published in:
- Hematological Oncology, 2023, v. 41, p. 344, doi. 10.1002/hon.3164_246
- By:
- Publication type:
- Article
Automated FDG PET/CT radiomics for risk stratification in newly diagnosed diffuse large B‐cell lymphoma (DLBCL).
- Published in:
- Hematological Oncology, 2023, v. 41, p. 341, doi. 10.1002/hon.3164_244
- By:
- Publication type:
- Article
IMPACT OF TIME TO RELAPSE AND RESPONSE TO SALVAGE THERAPY ON POST AUTOLOGOUS STEM CELL TRANSPLANT OUTCOMES IN RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.98_2880
- By:
- Publication type:
- Article
PROGRESSION‐FREE SURVIVAL AT 24 MONTHS AS A LANDMARK AFTER AUTOLOGOUS STEM CELL TRANSPLANT IN RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.97_2880
- By:
- Publication type:
- Article
INTERIM PET/CT PREDICTS OUTCOMES OF DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) TREATED WITH FRONTLINE LENALIDOMIDE/RCHOP (R2CHOP): LONG‐TERM ANALYSIS OF MC078E.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.83_2880
- By:
- Publication type:
- Article
DO CELL‐OF‐ORIGIN, DOUBLE EXPRESSER, AND DOUBLE HIT STATUS AFFECT OUTCOMES IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA (R/R DLBCL)? A PROSPECTIVE OBSERVATIONAL STUDY.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.66_2879
- By:
- Publication type:
- Article
S-phase fraction by the labeling index as a predictive factor for progression and survival in low grade non-Hodgkin's lymphoma.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Primary renal non-Hodgkin's lymphoma. An unusual extranodal site.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Prognostic value of c-erbB2 overexpression in axillary lymph node positive breast cancer. Results from a randomized adjuvant treatment protocol.
- Published in:
- 1994
- By:
- Publication type:
- journal article
DNA ploidy and the percentage of cells in S-phase as prognostic factors for women with lymph node negative breast cancer.
- Published in:
- 1994
- By:
- Publication type:
- journal article